DOI:
10.1055/s-00000105
Zentralblatt für Gynäkologie
LinksClose Window
References
Mass R, Press M, Anderson S, Slamon D.
Improved survival benefit from Herceptin (trastuzumab) and chemotherapy in patients selected by fluorescence in situ hybridisation.
Breast Canc Res Treat 2001; 69 (Abstract 18): 213
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.